An Orthotopic Model of Pancreatic Somatostatin Receptor (SSTR)-Positive Tumors Allows Bimodal Imaging Studies Using 3T MRI and Animal PET-Based Molecular Imaging of SSTR Expression

Lars Stelter,Holger Amthauer,A. Rexin,J. Pinkernelle,Petra Schulz,Roger Michel,Timm Denecke,Heiner Stiepani,Bernd Hamm,Bertram Wiedenmann,Arne Scholz

An Orthotopic Model of Pancreatic Somatostatin Receptor (SSTR)-Positive Tumors Allows Bimodal Imaging Studies Using 3T MRI and Animal PET-Based Molecular Imaging of SSTR Expression

2008

Lars Stelter
Holger Amthauer
A. Rexin
J. Pinkernelle
Petra Schulz
Roger Michel
Timm Denecke
Heiner Stiepani
Bernd Hamm
Bertram Wiedenmann
Arne Scholz

Somatostatin receptor (SSTR) scintigraphy is currently used as one standard imaging modality in neuroendocrine tumors (NETs). However, future optimization of NET imaging may be achieved with positron

Keywords:

Scintigraphy
Somatostatin receptor
Positron emission tomography
Internal medicine
Endocrinology
Molecular imaging
Magnetic resonance imaging
Neuroendocrine tumors
Pancreatic tumor
Pancreas
Pathology
Biology
animal pet
Pancreatic disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations